↓ Skip to main content

The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice

Overview of attention for article published in Frontiers in Pharmacology, June 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
2 X users
video
1 YouTube creator

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice
Published in
Frontiers in Pharmacology, June 2023
DOI 10.3389/fphar.2023.1208044
Pubmed ID
Authors

Amer H. Asseri, Tahani Bakhsh, Samah Sulaiman Abuzahrah, Sajad Ali, Irfan A. Rather

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 23%
Student > Ph. D. Student 4 15%
Student > Doctoral Student 1 4%
Librarian 1 4%
Other 1 4%
Other 1 4%
Unknown 12 46%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 19%
Nursing and Health Professions 3 12%
Medicine and Dentistry 3 12%
Immunology and Microbiology 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 0 0%
Unknown 13 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2024.
All research outputs
#16,310,471
of 26,206,339 outputs
Outputs from Frontiers in Pharmacology
#5,537
of 20,167 outputs
Outputs of similar age
#191,221
of 393,635 outputs
Outputs of similar age from Frontiers in Pharmacology
#130
of 771 outputs
Altmetric has tracked 26,206,339 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,167 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,635 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 771 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.